Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Neurobiology of Disease|December 3, 2014
α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9)Guillaume Daniel, Alessandra Musso, Elpida Tsika, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 21, 2011
A rat model of progressive nigral neurodegeneration induced by the Parkinson's disease-associated G2019S mutation in LRRK2Julien Dusonchet, Olexiy Kochubey, Klodjan Stafa, et al.
Human Molecular Genetics|November 5, 2004
Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stressDarren J Moore, Li Zhang, Juan Troncoso, et al.
Human Molecular Genetics|January 6, 2017
Parkin functionally interacts with PGC-1α to preserve mitochondria and protect dopaminergic neuronsLu Zheng, Nathalie Bernard-Marissal, Norman Moullan, et al.
Plos One|October 20, 2012
Phosphorylation of 4E-BP1 in the mammalian brain is not altered by LRRK2 expression or pathogenic mutationsAlzbeta Trancikova, Adamantios Mamais, Philip J Webber, et al.
Journal of Neurochemistry|November 15, 2006
Expression and localization of Parkinson's disease-associated leucine-rich repeat kinase 2 in the mouse brainShinji Higashi, Darren J Moore, Rebecca E Colebrooke, et al.
Human Molecular Genetics|December 22, 2011
PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrityDavid Ramonet, Agata Podhajska, Klodjan Stafa, et al.
Pageof 10